Investors Should Take Note Of LAVA Therapeutics NV (LVTX)
Morgan Stanley & Co. LLC has recently announced that it has increased stake in LAVA Therapeutics NV (NASDAQ:LVTX) by 0.98%. After grabbing 10300.0 shares, the institutional investor is now in possession of 100.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.04% having worth around $16274.0. LAVA Therapeutics […]
